Ansiedad

2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide (HMO) in breast milk and is recognized for supporting infant and child immune development. Clinical studies in infants fed formula supplemented with 2'-FL reported reductions in parent-reported infections and illnesses. It acts as a prebiotic and prevents pathogen adhesion to epithelial surfaces, modulating gut-associated immunity.

A 12-week clinical study in 507 children aged 3–12 years examined larch arabinogalactan's effect on immune health; children aged 7–9 who consumed LA showed lower illness duration and fewer episodes compared to control groups. This pilot clinical finding, combined with mechanistic data on NK cell activation and prebiotic effects, provides initial scientific support for LA in children's immune health.

Pilot clinical studies show that B. clausii administration in children reduces the frequency and duration of recurrent respiratory infections and modulates immune cytokine profiles. In children with allergic rhinitis, B. clausii significantly shifts cytokine balance away from pro-allergic Th2 polarization. Immunological endpoints including IFN-γ, IL-12, TGF-β, and IL-10 were significantly altered in pediatric studies.

Beta-glucans are biologically active polysaccharides from yeast, mushrooms, and cereals that prime innate immune responses in children. A RCT in 174 children aged 1–4 years found baker's yeast beta-glucan (35–75 mg/day for 12 weeks) reduced the duration and number of upper respiratory tract infections versus placebo. A 2022 review confirmed immunomodulatory and infection-resistance benefits specific to pediatric populations.

Bifidobacterium species are dominant probiotic organisms in the infant gut microbiome and play a fundamental role in immune system maturation and protection from respiratory and gastrointestinal infections. Multiple RCTs and a 2015 Cochrane review found Bifidobacterium-containing probiotic supplements reduced URTI frequency, duration, and antibiotic use in children. A 2025 double-blind RCT in children with recurrent RTIs confirmed significant clinical benefit.

B. animalis subsp. lactis BB-12 has been documented across multiple clinical trials in infants and children for immune-related outcomes, including reduced risk of infections, increased secretory IgA, and modulation of immune markers. A 2016 review noted BB-12 reduces the risk of infections in early childhood. HN019 supports normal immune function in clinical human studies by competing and excluding potential pathogens.

Bifidobacterium bifidum is a clinically studied probiotic strain for children's immune and respiratory health. In combination with other Lactobacillus and Bifidobacterium strains, B. bifidum supplementation was shown to prevent URTIs and reduce antibiotic use in preschool children. It is a component of the ProbioKid formulation shown to decrease respiratory infection rates in children supplemented for 3–9 months.

Bifidobacterium breve is a probiotic strain prominent in infant gut microbiome with evidence for supporting children's immune responses against respiratory infections. It is being evaluated in a registered RCT (NCT07498127) specifically in children aged 3 months to 6 years with URTI. B. breve supports immune development through modulation of secretory IgA and cytokine profiles.

Bifidobacterium infantis is a dominant bifidobacterium in breastfed infant gut microbiome and is incorporated in pediatric probiotic formulations for immune support. Clinical studies of combinations including B. infantis show reduced rates of respiratory infections in infants and young children. It is part of the ProbioKid® formulation with clinical evidence for URTI prevention in children supplemented for 3–9 months.

Bifidobacterium lactis (animalis subsp. lactis) is among the most clinically validated probiotic strains for children's immune and respiratory health. A 2025 double-blind RCT in 120 children with recurrent RTIs found Bifidobacterium animalis subsp. lactis XLTG11 plus Lactiplantibacillus plantarum significantly reduced frequency and duration of respiratory infections, fever, cough, and pneumonia versus placebo. It strongly enhances secretory IgA levels.

Bifidobacterium longum is a key gut probiotic with documented benefits for children's immune health. A 2025 RCT of B. longum subsp. infantis B8762 in 115 infants found supplementation reduced infection duration and lowered clinical visits for respiratory and gastrointestinal illness. B. longum supports IgA production and anti-inflammatory cytokine responses in the gut-lung immune axis.

Cod liver oil's vitamins A and D regulate immune function in children. Observational data from Norway associate CLO use in the first year of life with lower risk of type 1 diabetes. Vitamin A reduces severity of childhood infections such as measles, and cod liver oil has been used for centuries to support immune resilience in children.

Bovine colostrum is rich in immunoglobulins, lactoferrin, lysozyme, and growth factors, and has been used traditionally and increasingly studied clinically to support immune defense in children. A 2023 RCT in pre-school children found 6 weeks of bovine colostrum supplementation reduced days with upper respiratory tract infection symptoms by 31% and symptom severity by 37%, with effects lasting up to 20 weeks post-supplementation.

Echinacea, particularly E. purpurea, has been used traditionally in North America and Europe for immune support and is one of the most clinically researched botanicals for respiratory infections. An RCT of 200 healthy children found echinacea use prevented respiratory infections and reduced antibiotic prescriptions by 76.3%. NCCIH reports that one recent study found echinacea might reduce respiratory tract infection risk and complications in children, though overall evidence is mixed.

Echinacea purpurea is the most studied Echinacea species for children's immune and respiratory health. Clinical trials specifically using E. purpurea demonstrated reduced respiratory tract infection rates and reduced antibiotic use in children. A 2025 systematic review and meta-analysis confirmed efficacy for treating URTI and otitis media complications in children.

Elderberry (Sambucus nigra) has been traditionally used in European folk medicine for centuries and is among the most clinically researched botanicals for viral respiratory illness support. A systematic review found elderberry may reduce duration and severity of influenza-like symptoms. Its anthocyanins inhibit viral glycoproteins, exhibit in vitro antiviral activity against influenza A and B, and modulate cytokine production.

Fructooligosaccharides (FOS) are well-established prebiotic fibers that selectively promote beneficial gut bacteria (particularly Bifidobacterium) and enhance gut-associated immune responses in children. FOS-containing synbiotic formulations (combined with probiotic strains) demonstrated reduced RTI incidence, duration, and severity in three separate large RCTs. They stimulate macrophage activity and promote intestinal secretory IgA production.

Galactooligosaccharides (GOS) are prebiotic fibers that promote Bifidobacterium growth in the infant and child gut and have been used in infant formula to support immune development. GOS combined with probiotic strains significantly reduced RTI incidence and severity in multiple large RCTs. GOS also enhances macrophage activity and intestinal IgA production relevant to mucosal immunity.

Garlic has a long traditional history of use for immune and respiratory support in cultures worldwide and was included in a key NIH ODS systematic review of immune supplement ingredients. Its active compounds (allicin, alliin, diallyl sulfide) exhibit antimicrobial and immunomodulatory properties. One study found garlic supplementation for 12 weeks resulted in fewer colds and shorter illness duration compared to placebo.

Honey has been shown in multiple pediatric RCTs to reduce the frequency, severity, and duration of cough associated with upper respiratory infections, effectively supporting children's immune response to common viral illness. Cochrane evidence (2018, 6 RCTs, 899 children) confirms honey is superior to placebo and no-treatment for cough symptoms. Traditional use in pediatric febrile illness spans ancient medical systems.

SBI has been shown to support gut-associated immune reconstitution in children and adults through increased mucosal CD4+ T-cell counts and reduced inflammatory markers. Pediatric clinical studies of SBI in IBS confirm it is safe and well-tolerated in children, with immune-modulating properties linked to IgG-mediated antigen binding in the gut.

Lactobacillus acidophilus is a well-studied probiotic strain used in combination formulations to reduce upper respiratory tract infections in children. A preschool-dose clinical study combining L. acidophilus CUL21 and CUL60 with Bifidobacterium strains and vitamin C was effective in preventing URTIs and reducing antibiotic use in children. It supports mucosal immunity via IgA enhancement and gut microbiota balance.

L. casei Shirota has been investigated in children for immune modulation and reduction of respiratory infections. An RCT of 518 children showed that L. casei Shirota as adjunct to antibiotic therapy significantly reduced treatment failure rates in fast breathing pneumonia. L. casei is also known to enhance macrophage, NK cell, and sIgA activity, supporting innate and adaptive immune responses in pediatric populations.

L. paracasei has been tested in pediatric immune contexts including asthma, allergic rhinitis, and celiac disease autoimmunity. A double-blind RCT in 160 asthmatic children showed L. paracasei (LP) alone or combined with L. fermentum improved asthma severity scores and immune biomarkers over 3 months. GM-080 ameliorated sneezing and global assessment scores in children with perennial allergic rhinitis.

Lactobacillus plantarum (now Lactiplantibacillus plantarum) is a clinically studied probiotic strain supporting children's immune defenses against respiratory infections. A 2025 double-blind RCT in 120 children with recurrent RTIs found L. plantarum CCFM8661 combined with B. animalis subsp. lactis significantly reduced respiratory infection frequency, duration, and severity including pneumonia and bronchitis.

Lactobacillus rhamnosus (especially the LGG strain) is among the most extensively studied probiotics for reducing respiratory tract infections in children. In a RCT of 281 children in daycare, LGG significantly reduced upper respiratory tract infections and lowered the risk of infections lasting more than 3 days. A 2015 Cochrane review found probiotics including Lactobacillus strains reduced URTI episodes, duration, and antibiotic use in children.

Lactoferrin is an iron-binding glycoprotein naturally present in breast milk with well-documented antimicrobial, anti-inflammatory, and immune-modulating properties in infants and children. A 2022 systematic review and meta-analysis of 25 studies found lactoferrin supplementation reduced respiratory tract infection incidence specifically in infants and children (not adults). A 2024 RCT in preschool children showed it reduced respiratory infection episodes by 50%.

Vitamin A palmitate supplementation in vitamin A–deficient children robustly improves immune function, reduces severity of infections, and lowers mortality from measles and diarrhea. WHO and UNICEF recommend periodic high-dose supplementation as a public health measure.

Propolis is a resin-like substance collected by honeybees with documented antimicrobial and immunomodulatory properties. Clinical trials have shown propolis reduces the incidence and duration of upper respiratory tract infections, including in children. It exerts broad-spectrum antiviral and antibacterial activity alongside stimulation of macrophage and NK cell activity.

Multiple RCTs and a systematic meta-analysis demonstrate that S. boulardii reduces diarrhea duration and hospitalisation in children with acute gastroenteritis. It stimulates secretory IgA production and decreases C-reactive protein, reflecting direct immunomodulatory activity in pediatric populations. Evidence is strongest for acute gastroenteritis and prevention of antibiotic-associated diarrhea.

S. thermophilus modulates immune gene expression in human immune cells and has been studied in pediatric formulas and probiotic preparations. The VSL#3 preparation containing S. thermophilus has clinical evidence in children with ulcerative colitis, where immune modulation is a key mechanism. Evidence in healthy children's immune function specifically is more limited.

Vitamin A is critical for mucosal immune defense, immune cell differentiation, and maintenance of epithelial barriers in children. WHO-endorsed supplementation programs targeting vitamin A-deficient children have demonstrated significant reductions in infectious disease mortality and morbidity. Retinoic acid induces T-cell gut homing and IgA secretion critical for mucosal immunity.

Vitamin C is essential for immune cell function and represents one of the most established nutritional supports for immune health in children. Regular supplementation reduces common cold duration by 14% in children (vs. 8% in adults) according to a large review of 82 studies. Vitamin C supports physical barriers, innate immunity, and adaptive immune responses.

Vitamin D is critical for immune regulation in children, with deficiency strongly associated with increased susceptibility to respiratory infections. A major 2017 BMJ meta-analysis of 25 RCTs found vitamin D supplementation protected against acute respiratory infections, with the strongest benefit in deficient individuals. Year-round supplementation of 400–1,000 IU/day is recommended for most children.

Vitamin D3 (cholecalciferol) is the preferred supplemental form of vitamin D for children's immune health. Pediatric immune support protocols specifically recommend vitamin D3 year-round at 400–1,000 IU/day. D3 is more effective than D2 at raising serum 25(OH)D levels and demonstrates superior immunomodulatory activity in respiratory infection prevention trials.

Vitamin E (primarily alpha-tocopherol) is a fat-soluble antioxidant that supports lymphocyte proliferation and T-cell-mediated immunity in children. It was identified as one of eight core single-ingredient immune supplement ingredients in a 2022 NIH ODS systematic review of 39 RCTs. Vitamin E enhances the immune response to vaccines and supports mucosal immune defenses.

Zinc is an essential micronutrient required for proper immune cell development and function in children. The WHO recommends zinc supplementation for children in high-burden regions, with clinical trials showing significant reductions in diarrheal disease and respiratory infection frequency and severity. Zinc supplementation can shorten common cold duration by approximately 33% and reduced hospital stays in pediatric pneumonia trials.